Trademark: 90760688
Status Date
Tuesday, April 11, 2023
Registration Number
7026905
Registration Date
Tuesday, April 11, 2023
Filing Date
Tuesday, June 8, 2021
Published for Opposition
Tuesday, April 5, 2022
5 Pharmaceutical preparations for human use, namely, pharmaceutical preparations for the prevention and treatment of multiple sclerosis
The wording BRIUMVI has no meaning in a foreign language.
Apr 11, 2023
Notice Of Registration Confirmation Emailed
Apr 11, 2023
Registered-Principal Register
Mar 7, 2023
Notice Of Acceptance Of Statement Of Use E-Mailed
Mar 6, 2023
Allowed Principal Register - Sou Accepted
Mar 3, 2023
Statement Of Use Processing Complete
Feb 8, 2023
Use Amendment Filed
Feb 27, 2023
Case Assigned To Intent To Use Paralegal
Feb 8, 2023
Teas Statement Of Use Received
Nov 29, 2022
Notice Of Approval Of Extension Request E-Mailed
Nov 27, 2022
Sou Extension 1 Granted
Nov 27, 2022
Sou Extension 1 Filed
Nov 27, 2022
Teas Extension Received
May 31, 2022
Noa E-Mailed - Sou Required From Applicant
Apr 5, 2022
Official Gazette Publication Confirmation E-Mailed
Apr 5, 2022
Published For Opposition
Mar 16, 2022
Notification Of Notice Of Publication E-Mailed
Feb 28, 2022
Approved For Pub - Principal Register
Feb 25, 2022
Assigned To Examiner
Oct 18, 2021
Teas Amendment Entered Before Attorney Assigned
Oct 18, 2021
Teas Voluntary Amendment Received
Aug 28, 2021
New Application Office Supplied Data Entered
Jun 11, 2021
New Application Entered
Trademark Alertz updated from USPTO on 2030-01-24
